925
Views
43
CrossRef citations to date
0
Altmetric
Review

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review

, , , , , & show all
Pages 1543-1569 | Published online: 22 Aug 2014

References

  • American Psychiatric AssociationThe Diagnostic and Statistical Manual of Mental Disorders5th editionArlington, VAAmerican Psychiatric Association2013
  • PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
  • BrownTEADHD Comorbidities: Handbook for ADHD Complications in Children and AdultsWashington, DCAmerican Psychiatric Press2009
  • WuEQHodgkinsPBen-HamadiRCost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature reviewCNS Drugs201226758160022712698
  • Subcommittee on Attention-Deficit/Hyperactivity DisorderSteering Committee on Quality Improvement and ManagementWolraichMBrownLBrownRTADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsPediatrics201112851007102222003063
  • FerrinMTaylorEChild and caregiver issues in the treatment of attention deficit–hyperactivity disorder: education, adherence and treatment choiceFuture Neurol201163399413
  • ZetterqvistJAshersonPHalldnerLLångströmNLarssonHStimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009Acta Psychiatr Scand20131281707722943458
  • GarbeEMikolajczykRTBanaschewskiTDrug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort studyJ Child Adolesc Psychopharmacol201222645245823234588
  • HongJNovickDTreuerTPredictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East AsiaPatient Prefer Adherence2013798799524124351
  • AdlerLDNierenbergAAReview of medication adherence in children and adults with ADHDPostgrad Med2010122118419120107302
  • MannuzzaSKleinRGBesslerAMalloyPLaPadulaMAdult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric statusArch Gen Psychiatry19935075655768317950
  • ShawMHodgkinsPCaciHA systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentBMC Med2012109922947230
  • KleinRGMannuzzaSOlazagastiMAClinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years laterArch Gen Psychiatry201269121295130323070149
  • CharachAFernandezREnhancing ADHD medication adherence: challenges and opportunitiesCurr Psychiatry Rep201315737123712722
  • WongICAshersonPBilbowACessation of attention deficit hyperactivity disorder drugs in the young (CADDY) – a pharmacoepidemiological and qualitative studyHealth Technol Assess20091350iiiivixxi112019883527
  • Ovid MedLine [database on the Internet]Bethesda, MDNational Library of Medicine Available from: http://site.ovid.com/products/ovidguide/premdb.htmAccessed January 11, 2014
  • MEDLINE® [database on the Internet]Bethesda, MDNational Library of Medicine Available from: http://www.nlm.nih.gov/pubs/factsheets/medline.htmlAccessed October 21, 2013
  • Embase [database on the Internet]Philadelphia PAElsevier Inc Available from: http://www.elsevier.com/online-tools/embase/aboutAccessed January 11, 2014
  • PsycINFO [database on the Internet]Washington, DCAmerican Psychological Association Available from: http://www.apa.org/pubs/databases/psycinfo/index.aspx?utm_source=BenchmarkEmail&utm_campaign=0319-part01&utm_medium=emailAccessed January 15, 2014
  • Cochrane Database of Systematic Reviews (CDSR) [database on the Internet]LondonThe Cochrane Collaboration Available from: http://www.cochrane.org/editorial-and-publishing-policy-resource/cochrane-database-systematic-reviews-cdsrAccessed January 11, 2014
  • MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
  • GreenhalghTPeacockREffectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sourcesBMJ200533175241064106516230312
  • LageMHwangPEffect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatmentJ Child Adolesc Psychopharmacol200414457558115662149
  • SanchezRJCrismonMLBarnerJCBettingerTWilsonJPAssessment of adherence measures with different stimulants among children and adolescentsPharmacotherapy200525790991716006269
  • McCarthySAshersonPCoghillDAttention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adultsBr J Psychiatry2009194327327719252159
  • JohnstonJAYeWVan BruntDLPohlGSumnerCRDecreased use of clonidine following treatment with atomoxetine in children with ADHDJ Clin Psychopharmacol200626438939516855457
  • BokhariFASHeilandFLevinePRayGTRisk factors for discontinuing drug therapy among children with ADHDHealth Serv Outcomes Res Methodol200883134158
  • BejerotSRydénEMArlindeCMTwo-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective studyJ Clin Psychiatry201071121590159720584517
  • LachaineJBeaucheminCSasaneRHodgkinsPSTreatment patterns, adherence, and persistence in ADHD: a Canadian perspectivePostgrad Med2012124313914822691908
  • LawsonKAJohnsrudMHodgkinsPSasanéRCrismonMLUtilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid programClin Ther2012344944956.e422444786
  • PottegårdABjerregaardBKGlintborgDKortegaardLSHallasJMorenoSIThe use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspectiveEur J Clin Pharmacol201369358959822811260
  • HodgkinsPSasanéRMeijerWMPharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the NetherlandsClin Ther201133218820321497704
  • DidoniASequiMPaneiPBonatiMLombardy ADHD Registry GroupOne-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorderEur J Clin Pharmacol201167101061106721538145
  • ChenCYYehHHChenKHChangISWuECLinKMDifferential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201121326527321663429
  • PalliSRKamblePSChenHAparasuRRPersistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201222213914822364400
  • MarcusSCWanGJKemnerJEOlfsonMContinuity of methylphenidate treatment for attention-deficit/hyperactivity disorderArch Pediatr Adolesc Med2005159657257815939858
  • BarnerJCKhozaSOladapoAADHD medication use, adherence, persistence and cost among Texas Medicaid childrenCurr Med Res Opin201127Suppl 2132221973228
  • ChristensenLSasanéRHodgkinsPHarleyCTetaliSPharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care populationCurr Med Res Opin201026497798920178404
  • HodgkinsPSasanéRChristensenLHarleyCLiuFTreatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care populationCurr Med Res Opin201127Suppl 2536221973231
  • GoetzMYehCBOndrejkaIA 12-month prospective, observational study of treatment regimen and quality of life associated with ADHD in central and eastern europe and eastern AsiaJ Atten Disord2012161445920858785
  • SikiricaVPliszkaSRBettsKAComparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychoticsJ Manag Care Pharm201218967668923206211
  • SetyawanJHodgkinsPGuérinAComparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysisJ Med Econ201316796297523621503
  • LensingMBZeinerPSandvikLOpjordsmoenSFour-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire surveyJ Clin Psychiatry2013741e87e9323419235
  • BowenJFentonTRappaportLStimulant medication and attention deficit-hyperactivity disorder. The child’s perspectiveAm J Dis Child199114532912952003477
  • BauermeisterJJCaninoGBravoMStimulant and psychosocial treatment of ADHD in Latino/Hispanic childrenJ Am Acad Child Adolesc Psychiatry200342785185512819445
  • ErcanESKoseSKutluAAkyolODurakSAydinCTreatment duration of children with attention deficit hyperactivity disorder is related to functioning and prognosisBulletin of Clinical Psychopharmacology2012222148160
  • dosReisSButzALipkinPHAnixtJSWeinerCLChernoffRAttitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city communityJ Behav Health Serv Res200633442343017078011
  • NiederkirchnerKSlawikLWermelskirchenDRettigKSchäubleBTransitioning to OROS® methylphenidate from atomoxetine is effective in children and adolescents with ADHDExpert Rev Neurother201111449950821469923
  • GauSSChenSJChouWJNational survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in TaiwanJ Clin Psychiatry200869113114018312048
  • KemnerJELageMJImpact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysisAnn Gen Psychiatry20065516606463
  • MarcusSCDurkinMStimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry201150548048921515197
  • MarcusSCWanGJZhangHFOlfsonMInjury among stimulant-treated youth with ADHDJ Atten Disord2008121646917934179
  • SikiricaVXieJHeTLImmediate-release versus extended-release guanfacine for treatment of attention-deficit/hyperactivity disorderAm J Pharm Benefits201354e85e94
  • SalonerBFullertonCMcGuireTThe impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparitiesJ Child Adolesc Psychopharmacol201323640140923952187
  • Ramos-QuirogaJABoschRCastellsXEffect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorderCNS Drugs200822760361118547128
  • GimpelGACollettBRVeederMAEffects of stimulant medication on cognitive performance of children with ADHDClin Pediatr (Phila)200544540541115965546
  • ColettiDJPappadopulosEKatsiotasNJBerestAJensenPSKafantarisVParent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201222322623722537185
  • ChouWJChouMCTzangRFBetter efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate- release methylphenidate in the three ADHD subtypesPsychiatry Clin Neurosci200963216717519335386
  • GauSSShenHYChouMCTangCSChiuYNGauCSDeterminants of adherence to methylphenidate and the impact of poor adherence on maternal and family measuresJ Child Adolesc Psychopharmacol200616328629716768636
  • SitholeyPAgarwalVChamoliSA preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorderIndian J Psychiatry2011531414421431007
  • ThiruchelvamDCharachASchacharRJModerators and mediators of long-term adherence to stimulant treatment in children with ADHDJ Am Acad Child Adolesc Psychiatry200140892292811501692
  • Ibrahim elSRRates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorderHum Psychopharmacol200217522523112404679
  • Hervey-JumperHDouyonKFrancoKNDeficits in diagnosis, treatment and continuity of care in African–American children and adolescents with ADHDJ Natl Med Assoc200698223323816708509
  • HodgkinsPSetyawanJMitraDManagement of ADHD in children across Europe: patient demographics, physician characteristics and treatment patternsEur J Pediatr2013172789590623440479
  • RothenbergerABeckerABreuerDDöpfnerMAn observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherenceEur Child Adolesc Psychiatry201120Suppl 2S257S26521901416
  • MazzoneLRealeLManninoVCocuzzaMVitielloBLower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorderCNS Drugs201125650350921649450
  • TorresAWhitneyJRaoSTilleyCLobelRGonzalez-HeydrichJTolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsyEpilepsy Behav20112019510221146461
  • ScottNGRipperger-SuhlerJRajabMHKjarDFactors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescentsJ Child Adolesc Psychopharmacol201020319720320578932
  • BanerjeeSUse of atomoxetine in children and adolescents with ADHDProg Neurol Psychiatry20091321820
  • DarredeauCBarrettSPJardinBPihlROPatterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate usersHum Psychopharmacol200722852953617910020
  • RothenbergerARothenbergerLGUpdates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerationsCurr Treat Options Neurol201214659460722968494
  • AshtonHGallagherPMooreBThe adult psychiatrist’s dilemma: psychostimulant use in attention deficit/hyperactivity disorderJ Psychopharmacol200620560261016478756
  • SchlanderMIs NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD)Curr Med Res Opin200824251553518186971
  • BuitelaarJMedoriRTreating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsEur Child Adolesc Psychiatry201019432534019823900
  • GrahamJBanaschewskiTBuitelaarJEuropean Guidelines GroupEuropean guidelines on managing adverse effects of medication for ADHDEur Child Adolesc Psychiatry2011201173721042924
  • DodsonWWPharmacotherapy of adult ADHDJ Clin Psychol200561558960615723384
  • RöslerMCasasMKonofalEBuitelaarJAttention deficit hyperactivity disorder in adultsWorld J Biol Psychiatry201011568469820521876
  • GrahamLPractice guidelines: AHA releases recommendations on cardiovascular monitoring and the use of ADHD medications in children with heart diseaseAm Fam Physician20097910905910
  • CouryDDexmethylphenidate for attention deficit hyperactivity disorderExpert Opin Pharmacother200910162679268519874250
  • GreenhillLLPliszkaSDulcanMKAmerican Academy of Child and Adolescent PsychiatryPractice parameter for the use of stimulant medications in the treatment of children, adolescents, and adultsJ Am Acad Child Adolesc Psychiatry2002412 Suppl26S49S11833633
  • Van CleaveJLeslieLKApproaching ADHD as a chronic condition: implications for long-term adherenceJ Psychosoc Nurs Ment Health Serv2008468283718777966
  • KarveSClevesMAHelmMHudsonTJWestDSMartinBCGood and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurr Med Res Opin20092592303231019635045
  • CramerJARosenheckRCompliance with medication regimens for mental and physical disordersPsychiatr Serv19984921962019575004
  • ChapmanSCHorneRMedication nonadherence and psychiatryCurr Opin Psychiatry201326544645223880592
  • VelliganDIWeidenPJSajatovicMExpert Consensus Panel on Adherence Problems in Serious and Persistent Mental IllnessThe expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessJ Clin Psychiatry200970Suppl 4146 quiz 4719686636
  • Dunbar-JacobJMortimer-StephensMKTreatment adherence in chronic diseaseJ Clin Epidemiol200154Suppl 1S57S6011750211
  • YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
  • Centers for Disease Control and Prevention [homepage on the Internet]Attention-Deficit/Hyperactivity Disorder (ADHD)Atlanta, GACenters for Disease Control and Prevention2013 [update July 3, 2013]. Available from: http://www.cdc.gov/ncbddd/adhd/guidelines.htmlAccessed March 19, 2014
  • National Institute for Health and Clinical ExcellenceAttention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adultsManchester, UKNICE2013 Available from: http://www.nice.org.uk/nicemedia/live/12061/42059/42059.pdfAccessed March 19, 2014
  • CascadeEKalaliAHWeislerRHShort-acting versus long-acting medications for the treatment of ADHDPsychiatry (Edgmont)200858242719727272
  • SikiricaVFridmanMBrunoAHodgkinsPErderMHConcomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorderDrugs R D201313427128024271555
  • National Institute of Mental HealthMental Health MedicationsBethesda, MDNational Institute of Mental Health2008 Available from: http://www.nimh.nih.gov/health/publications/mental-health-medications/index.shtml#pub8Accessed March 7, 2014
  • Canadian Attention Deficit Hyperactivity Disorder Resource AllianceCanadian ADHD Practice GuidelinesToronto, ONCanadian Attention Deficit Hyperactivity Disorder Resource Alliance2011 Available from: http://www.caddra.ca/pdfs/caddraGuidelines2011.pdfAccessed March 7, 2014
  • FaraoneSVAnsthelKMDiagnosing and treating attention-deficit/hyperactivity disorder in adultsWorld Psychiatry20087313113618836579